View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Trastuzumab 6, maintenance, adenocarcinoma esophagogastric junction and stomach
Protocol-ID: 222 V1.1 (Mini), TRAS6 maint., AEG/Gastric CaIndication(s)
- Gastric Cancer (HER2+); ICD-10 C16.-, C16.0
- Esophageal Cancer (Adenocarcinoma of the esophagogastric junction (AEG), HER2+); ICD-10 C15.-
Links
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 04.07.2021